Glucocorticoid effects on myocardial performance in patients with systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 19, Issue 4, 2001, Pages 431-437

  Antoniades, L ^a   Sfikakis, P P ^a   Mavrikakis, M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cardiac involvement; Ejection fraction; Lupus erythematosus; Prednisolone; Radionuclide ventriculography; Rheumatoid arthritis; Systemic; Systemic sclerosis

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN G; PREDNISOLONE; TECHNETIUM 99M;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; ERYTHROCYTE SEDIMENTATION RATE; ERYTHROCYTE VOLUME; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PERFORMANCE; HEART RATE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; PLASMA VOLUME; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; REST; RHEUMATOID ARTHRITIS; SHORT COURSE THERAPY; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; GLUCOCORTICOIDS; HEART; HEART FUNCTION TESTS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MYOCARDIUM; PREDNISOLONE; RADIONUCLIDE VENTRICULOGRAPHY; SCLERODERMA, SYSTEMIC; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034919985     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Heart involvement in systemic sclerosis
2. Cardiac involvement in scleroderma
3. Pathologic observations in systemic sclerosis (scleroderma): A study of fifty-eight autopsy cases and fifty-eight matched controls
4. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction
5. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma)
6. Noninvasive evaluation of cardiac dysrhythmias, and their relationship with multisystemic symptoms, in progressive systemic sclerosis patients
7. Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis
8. Primary heart disease in systemic sclerosis (scleroderma): Advances in clinical and pathologic features, pathogenesis, and new therapeutic approaches
9. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis
10. Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis
11. Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril
12. Treatment of organ systems involvements: Cardiac
13. Clinical problems: The lungs
14. Pharmacologic approaches. Systemic corticosteroids in rheumatology
15. Radionuclide ventriculography: Methods
16. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
17. The 1982 revised criteria for the classification of systemic lupus erythematosus
18. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
19. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
20. Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: Validation of the technique and assessment of variability
21. In vivo labelling of red blood cells with Tc-99m: A new approach to blood pool visualisation
22. Diffusing capacity of the lung and nifedipine in systemic sclerosis
23. Cardiac performance in collagen diseases estimated by non-invasive methods
24. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis
25. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): A high risk association
26. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma
27. Clinical diagnosis of cardiac involvement in systemic lupus erythematosus. A correlation of clinical and autopsy findings in thirty patients
28. Cardiopulmonary manifestations of systemic lupus erythematosus
29. The heart in rheumatoid arthritis
30. Heart disease in patients with seropositive rheumatoid arthritis. A controlled autopsy study and review
31. Clucocorticoids, sympathetic activity, and pre-synaptic alpha 2-adrenoreceptor function in humans
32. The aetiopathogenesis of systemic sclerosis
33. Hypothesis for the pathogenesis of systemic sclerosis
34. Immunopathogenesis of systemic sclerosis